Rehabilitation of Conversion Gait Disorder

Conversion Disorder Clinical Trial

Official title:

Patients With Conversion Gait Disorder - Effect on Treatment and Common Gait Patterns. Randomized Clinical Trial

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT01422278
• Other study ID #: 2.2004.164
• Secondary ID: SSR.2005.1
• Status: Active, not recruiting
• Phase: Phase 1/Phase 2
• First received: January 16, 2006
• Last updated: August 22, 2011
• Start date: September 2007
• Est. completion date: December 2011

Study information

• Verified date: August 2011
• Source: Oslo University Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Norway:National Committee for Medical and Health Research Ethics
• Study type: Interventional

Clinical Trial Summary

Evaluating the effects in functional status after three weeks of cognitive - and behavioural rehabilitation on patients with gait disorder. The patients are followed up as after 1 and 12 months to study if any improvement is still present. The patients are being recruited from neurological units. The intervention is explanation of symptoms, positive reinforcement of normal behaviour and absence reinforcement of dysfunctional behaviour. In addition the study aims at describing typical gait patterns at patients with gait disorder by using biomechanical measurements (EKG).

Description:

Patients are being recruited from neurological unit/ div and out patients department of SSR and are randomized to treatment or control group. Essential gait disorders do to conversion symptoms and willingness to participate in either of the two groups with informed consent are required.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 60
• Est. completion date: December 2011
• Est. primary completion date: September 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 69 Years

Eligibility

Inclusion Criteria:

• To determine the changes in functional status after three weeks of multidisciplinary rehabilitation in patients with conversion walking disorder.

Exclusion Criteria:

• Essential gait disorders do to conversion symptoms and willingness to participate in either of the two groups with informed consent are required.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Conversion Disorder
• Dissociative Disorders

Intervention

Other:
• Rehabilitation
Three weeks of rehabilitation in Hospital.

Locations

Country	Name	City	State
Norway	Vestfold Hospital Trust, clinic physical medicine and rehabilitation	Stavern	Vestfold

Sponsors (2)

Lead Sponsor	Collaborator
Oslo University Hospital	Norwegian School of Sport Sciences

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in gait patterns		three weeks	No
Secondary	Improved life quality		12 months	No